Prolonged exposure to continuous renal replacement therapy in patients with acute kidney injury

Springer Science and Business Media LLC - Tập 35 - Trang 585-595 - 2021
Khaled Shawwa1,2, Panagiotis Kompotiatis1, Ankit Sakhuja3, Paul McCarthy3, Kianoush B. Kashani1,3,4
1Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, USA
2Section of Nephrology, Department of Medicine, West Virginia University, Morgantown, USA
3Division of Cardiovascular Critical Care, Department of Cardiovascular and Thoracic Surgery, Heart and Vascular Institute, West Virginia University, Morgantown, USA
4Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, USA

Tóm tắt

Little is known about the process of deciding to discontinue continuous renal replacement therapy (CRRT) in patients with acute kidney injury (AKI) and the impact of CRRT duration on outcomes. We report the clinical parameters of prolonged CRRT exposure and predictors of doubling of serum creatinine or need for dialysis at 90 days after CRRT with propensity score matching, including covariates that were likely to influence patients in the prolonged CRRT group. Among 104 survey responders, most use urine output (87%) to guide CRRT discontinuation, 24% use improvement in clinical or hemodynamic status. In the cohort study, of 854 included patients, 465 participated in the assessment of kidney recovery. Patients with prolonged CRRT had higher SOFA scores (11.9 vs. 11.2) and were more likely to be mechanically ventilated (99% vs. 84%) at CRRT initiation compared to patients without prolonged CRRT, p-value < 0.05. In multivariable logistic regression, daily urine output and cumulative fluid balance leading to CRRT discontinuation or day seven were independently associated with lower [OR 0.87 per 200 ml/day increase] and higher odds [OR 1.03 per 1-L increase] of requiring prolonged CRRT, respectively. After propensity score matching, prolonged exposure to CRRT was independently associated with increased risk of doubling serum creatinine or dialysis at 90 days, OR 3.1 (95% CI 1.23–8.3 p = 0.017). Resolution of critical illness and signs of kidney recovery are important factors when considering CRRT discontinuation. Prolonged CRRT exposure may be associated with less chance of kidney recovery among survivors.

Tài liệu tham khảo

Schiffl H, Lang SM, Fischer R (2012) Long-term outcomes of survivors of ICU acute kidney injury requiring renal replacement therapy: a 10-year prospective cohort study. Clin Kidney J 5(4):297–302. https://doi.org/10.1093/ckj/sfs070 Triverio PA, Martin PY, Romand J, Pugin J, Perneger T, Saudan P (2009) Long-term prognosis after acute kidney injury requiring renal replacement therapy. Nephrol Dial Transplant 24(7):2186–2189. https://doi.org/10.1093/ndt/gfp072 Griffin BR, Liu KD, Teixeira JP (2020) Critical care nephrology: core curriculum 2020. Am J Kidney Dis 75(3):435–452. https://doi.org/10.1053/j.ajkd.2019.10.010 Mendu ML, Ciociolo GR Jr, McLaughlin SR, Graham DA, Ghazinouri R, Parmar S, Grossier A, Rosen R, Laskowski KR, Riella LV, Robinson ES, Charytan DM, Bonventre JV, Greenberg JO, Waikar SS (2017) A decision-making algorithm for initiation and discontinuation of RRT in severe AKI. Clin J Am Soc Nephrol 12(2):228–236. https://doi.org/10.2215/cjn.07170716 Investigators S-A (2020) Timing of initiation of renal-replacement therapy in acute kidney injury. N Engl J Med 383(3):240–251. https://doi.org/10.1056/NEJMoa2000741 Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1–138 Kelly YP, Waikar SS, Mendu ML (2019) When to stop renal replacement therapy in anticipation of renal recovery in AKI: the need for consensus guidelines. Semin Dial 32(3):205–209. https://doi.org/10.1111/sdi.12773 Katulka RJ, Al Saadon A, Sebastianski M, Featherstone R, Vandermeer B, Silver SA, Gibney RTN, Bagshaw SM, Rewa OG (2020) Determining the optimal time for liberation from renal replacement therapy in critically ill patients: a systematic review and meta-analysis (DOnE RRT). Crit Care 24(1):50. https://doi.org/10.1186/s13054-020-2751-8 Palevsky PM, Baldwin I, Davenport A, Goldstein S, Paganini E (2005) Renal replacement therapy and the kidney: minimizing the impact of renal replacement therapy on recovery of acute renal failure. Curr Opin Crit Care 11(6):548–554. https://doi.org/10.1097/01.ccx.0000179936.21895.a3 Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Straaten HO, Ronco C, Kellum JA (2009) Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study. Crit Care Med 37(9):2576–2582. https://doi.org/10.1097/CCM.0b013e3181a38241 Bray BD, Boyd J, Daly C, Doyle A, Donaldson K, Fox JG, Innes A, Khan I, Mackinnon B, Peel RK, Shilliday I, Simpson K, Stewart GA, Traynor JP, Metcalfe W (2014) How safe is renal replacement therapy? A national study of mortality and adverse events contributing to the death of renal replacement therapy recipients. Nephrol Dial Transplant 29(3):681–687. https://doi.org/10.1093/ndt/gft197 von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 4(10):e296. https://doi.org/10.1371/journal.pmed.0040296 Palevsky PM, Molitoris BA, Okusa MD, Levin A, Waikar SS, Wald R, Chertow GM, Murray PT, Parikh CR, Shaw AD, Go AS, Faubel SG, Kellum JA, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene T, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA (2012) Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol 7(5):844–850. https://doi.org/10.2215/cjn.12791211 Shawwa K, Kompotiatis P, Jentzer JC, Wiley BM, Williams AW, Dillon JJ, Albright RC, Kashani KB (2019) Hypotension within one-hour from starting CRRT is associated with in-hospital mortality. J Crit Care 54:7–13. https://doi.org/10.1016/j.jcrc.2019.07.004 Ho Dei K, King G, Stuart EA (2011) MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw 4(8):1–28. https://doi.org/10.18637/jss.v042.i08 Joannidis M, Forni LG, Klein SJ, Honore PM, Kashani K, Ostermann M, Prowle J, Bagshaw SM, Cantaluppi V, Darmon M, Ding X, Fuhrmann V, Hoste E, Husain-Syed F, Lubnow M, Maggiorini M, Meersch M, Murray PT, Ricci Z, Singbartl K, Staudinger T, Welte T, Ronco C, Kellum JA (2020) Lung-kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup. Intensive Care Med 46(4):654–672. https://doi.org/10.1007/s00134-019-05869-7 Viallet N, Brunot V, Kuster N, Daubin D, Besnard N, Platon L, Buzançais A, Larcher R, Jonquet O, Klouche K (2016) Daily urinary creatinine predicts the weaning of renal replacement therapy in ICU acute kidney injury patients. Ann Intensive Care 6(1):71. https://doi.org/10.1186/s13613-016-0176-y Fröhlich S, Donnelly A, Solymos O, Conlon N (2012) Use of 2-hour creatinine clearance to guide cessation of continuous renal replacement therapy. J Crit Care 27(6):744.e741-745. https://doi.org/10.1016/j.jcrc.2012.08.012 Kim CS, Bae EH, Ma SK, Kim SW (2018) A prospective observational study on the predictive value of serum cystatin C for successful weaning from continuous renal replacement therapy. Kidney Blood Press Res 43(3):872–881. https://doi.org/10.1159/000490335 Yoshida T, Matsuura R, Komaru Y, Miyamoto Y, Yoshimoto K, Hamasaki Y, Noiri E, Morimura N, Nangaku M, Doi K (2019) Kinetic estimated glomerular filtration rate as a predictor of successful continuous renal replacement therapy discontinuation. Nephrology (Carlton) 24(3):287–293. https://doi.org/10.1111/nep.13396 Lorenzen JM, Broll M, Kaever V, Burhenne H, Hafer C, Clajus C, Knitsch W, Burkhardt O, Kielstein JT (2012) Pharmacokinetics of ampicillin/sulbactam in critically ill patients with acute kidney injury undergoing extended dialysis. Clin J Am Soc Nephrol 7(3):385–390. https://doi.org/10.2215/cjn.05690611 Seyler L, Cotton F, Taccone FS, De Backer D, Macours P, Vincent JL, Jacobs F (2011) Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy. Crit Care 15(3):R137. https://doi.org/10.1186/cc10257 Finkel KW, Podoll AS (2009) Complications of continuous renal replacement therapy. Semin Dial 22(2):155–159. https://doi.org/10.1111/j.1525-139X.2008.00550.x Pistolesi V, Zeppilli L, Fiaccadori E, Regolisti G, Tritapepe L, Morabito S (2019) Hypophosphatemia in critically ill patients with acute kidney injury on renal replacement therapies. J Nephrol 32(6):895–908. https://doi.org/10.1007/s40620-019-00648-5 Pistolesi V, Morabito S, Di Mario F, Regolisti G, Cantarelli C, Fiaccadori E (2019) A guide to understanding antimicrobial drug dosing in critically Ill patients on renal replacement therapy. Antimicrob Agents Chemother. https://doi.org/10.1128/aac.00583-19 Wu VC, Ko WJ, Chang HW, Chen YW, Lin YF, Shiao CC, Chen YM, Chen YS, Tsai PR, Hu FC, Wang JY, Lin YH, Wu KD (2008) Risk factors of early redialysis after weaning from postoperative acute renal replacement therapy. Intensive Care Med 34(1):101–108. https://doi.org/10.1007/s00134-007-0813-x Katayama S, Uchino S, Uji M, Ohnuma T, Namba Y, Kawarazaki H, Toki N, Takeda K, Yasuda H, Izawa J, Tokuhira N, Nagata I (2016) Factors predicting successful discontinuation of continuous renal replacement therapy. Anaesth Intensive Care 44(4):453–457. https://doi.org/10.1177/0310057x1604400401 Metnitz PG, Krenn CG, Steltzer H, Lang T, Ploder J, Lenz K, Le Gall JR, Druml W (2002) Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 30(9):2051–2058. https://doi.org/10.1097/00003246-200209000-00016 Morgera S, Kraft AK, Siebert G, Luft FC, Neumayer HH (2002) Long-term outcomes in acute renal failure patients treated with continuous renal replacement therapies. Am J Kidney Dis 40(2):275–279. https://doi.org/10.1053/ajkd.2002.34505 Wald R, Deshpande R, Bell CM, Bargman JM (2006) Survival to discharge among patients treated with continuous renal replacement therapy. Hemodial Int 10(1):82–87. https://doi.org/10.1111/j.1542-4758.2006.01179.x Vijayan A, Delos Santos RB, Li T, Goss CW, Palevsky PM (2018) Effect of frequent dialysis on renal recovery: results from the acute renal failure trial network study. Kidney Int Rep 3(2):456–463. https://doi.org/10.1016/j.ekir.2017.11.018 Wang Y, Gallagher M, Li Q, Lo S, Cass A, Finfer S, Myburgh J, Bouman C, Faulhaber-Walter R, Kellum JA, Palevsky PM, Ronco C, Saudan P, Tolwani A, Bellomo R (2018) Renal replacement therapy intensity for acute kidney injury and recovery to dialysis independence: a systematic review and individual patient data meta-analysis. Nephrol Dial Transplant 33(6):1017–1024. https://doi.org/10.1093/ndt/gfx308 Clark EG, Bagshaw SM (2015) Unnecessary renal replacement therapy for acute kidney injury is harmful for renal recovery. Semin Dial 28(1):6–11. https://doi.org/10.1111/sdi.12300